Latest International Sales News

Sigma Healthcare has delivered a robust first half of FY26, posting a 15% rise in revenue driven by strong domestic and international sales growth, alongside operational synergies and strategic store expansions.

Advanced Braking Technology Ltd reported a robust 27.2% revenue increase and a 61.6% rise in net profit for H1 2026, driven by strong international sales and progress in autonomous braking technology.

XRF Scientific has reported a record first half for December 2025, with revenue and profits rising on the back of strong mining demand and international expansion.

XRF Scientific has reported a solid half-year performance, with revenue climbing 9.1% to $31.3 million and net profit after tax up 6%, driven by strong demand in mining and a standout Precious Metals division.

HighCom Limited has announced a $7 million capital raise alongside a $1 million Share Purchase Plan to support working capital and product innovation, aiming for a strong revenue rebound and profitability in the second half of FY26.

RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.

Nuchev Limited reported a 19% decline in Q2 FY26 sales revenue, with steady retail performance in its Oli6® brand offset by a sharp drop in the Practitioner channel. The company remains debt-free and is advancing new product development to drive future growth.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Lark Distilling Co. has reported its sixth consecutive quarter of sales growth, with net sales rising 11% to $5 million in Q2 FY26, as it prepares to launch a refreshed brand portfolio domestically and internationally.

Vection Technologies has reported a remarkable quarter with a 250% jump in customer cash receipts and a landmark $7.8 million Defence order, signalling a new phase of growth and operational strength.

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.